Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
烽火通讯股价突破30元可能性分析
Type of publications
NITAG documentation (58)
Reports (3)
SAGE documentation (2)
Scientific publications (9)
Systematic reviews (SYSVAC) (374)
Regions
Africa (32)
Americas (30)
Eastern Mediterranean (3)
Europe (39)
South-East Asia (6)
Western Pacific (12)
Diseases
Cholera (1)
COVID-19 (193)
Dengue (3)
Diphtheria (4)
Haemophilus influenzae type B (5)
Hepatitis A (1)
Hepatitis B (19)
Herpes zoster (8)
HIV / AIDS (1)
Human papillomavirus (HPV) (35)
Influenza (52)
Japanese encephalitis (4)
Lyme disease, Borreliosis (1)
Measles (15)
Meningococcal disease (10)
Mpox (4)
Mumps (3)
Pertussis (8)
Pneumococcal disease (26)
Poliomyelitis (5)
Rotavirus (12)
RSV (Respiratory syncytial virus) (2)
Rubella (3)
Tetanus (8)
Tuberculosis (4)
Typhoid (5)
Varicella (5)
Yellow fever (3)
Show more
446 results found
2022
∙
NIAC
NIAC Recommendations for additional COVID-19 Booster Vaccination
2022
∙
ATAGI
ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years
2022
∙
ATAGI
ATAGI updated recommendations for a winter dose of COVID-19 vaccine
2022
∙
Conseil Supérieur de la Santé (CSS)
COVID-19 vaccination: Autumn / Winter season 2022 – 2023 in Belgium
2022
∙
ACIP
GRADE for Pfizer-BioNTech COVID-19 Vaccine for Children Aged 6 Months–4 Years
2022
∙
NACI
NACI Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
2022
∙
NIAC
NIAC recommendations for COVID-19 booster vaccination of those aged 12- 15 years
2022
∙
NACI, Public Health Agency of Canada
Recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants
2022
∙
STIKO
STIKO resolution on the 17th update of the COVID-19 vaccination recommendation
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register